Candidaemia in internal medicine departments: the burden of a rising problem

Clin Microbiol Infect. 2013 Jun;19(6):E281-4. doi: 10.1111/1469-0691.12155. Epub 2013 Feb 15.

Abstract

Although internal medicine wards (IMWs) represent a significant reservoir of patients with candidemia, few investigators have specifically addressed the epidemiological aspects of candidaemia in this population. Of all patients hospitalized during the study period with candidaemia, 133/348 (38%) were admitted to IMWs. Variables associated with IMWs included: antibiotic therapy prior to hospitalization, urinary or central venous catheter, parenteral nutrition, tumour and age >75 years. Overall, 30-day mortality in IMWs was significantly higher than that in other wards (51.1% vs. 38.2%, p <0.02). Multiple logistic regression analysis identified the administration of antifungal treatment 48 h after having the first positive BC as an independent determinant of hospital mortality. Patients with candidaemia in IMWs account for a substantial proportion of patients with candidaemia and have higher mortality compared with patients in other wards.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Candidemia / drug therapy
  • Candidemia / epidemiology*
  • Candidemia / etiology
  • Cross Infection*
  • Female
  • Hospital Mortality
  • Hospital Units*
  • Humans
  • Incidence
  • Internal Medicine*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Time Factors